Higher active p38β MAPK levels were detected in CWS, which was further increased in CWL (Figure 1B), suggesting that p38β MAPK is preferentially activated over other members of the p38 MAPK family in cancer patients with weight loss. The gene discussed is MAPK11; the disease is cancer.